Non-invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesiclesDanijela Koppers‐Lalic, Irene V. Bijnsdorp, Thomas Würdinger et al.|Oncotarget|2016Cited by 141
Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinionBertrand Tombal, Herman Stoevelaar, Filip Ameye et al.|World Journal of Urology|2011Cited by 19
A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate CancerJean de la Rosette, Pilar Laguna, José L. Domínguez-Escrig et al.|The Journal of Urology|2022Cited by 16
UP-02.172 The Appropriateness of Active Surveillance and the Impact of Prostate Cancer Gene 3 (PCA3) in Low Risk Prostate Cancer: An Analysis of Expert OpinionMark Speakman, Alessandro Volpe, J Schröder et al.|Urology|2011Cited by 0